Showing results (1111-1120 of 1,291) with videos related to
Sort By:
Pageof 130
Animal Reproduction Science|December 16, 2025
Suboptimal responses to E2/P4-based timed AI protocols compromise pregnancy outcomes in fertile beef cattle: Roles of ovulation timing and semen viabilityCésar Augusto Pinzón-Osorio, Thomaz Kranen Cunha, German Holguin-Sanabria, et al.BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)Fernando C Maluf, Fabio A Schutz, Eduardo H Cronemberger, et al.Lancet (London, England)|May 18, 2020
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trialMatthew D Galsky, José Ángel Arranz Arija, Aristotelis Bamias, et al.Medicina|November 7, 2013
[Venous thromboembolic prophylaxis. Guidelines for adults in Argentina]Fernando Javier Vázquez, Esteban Lifschitz, Ricardo Watman, et al.The New England Journal of Medicine|September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaRobert J Motzer, Bernard Escudier, David F McDermott, et al.JCO Global Oncology|April 15, 2021
Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing CountriesFernando S M Monteiro, Fabio A Schutz, Igor A P Morbeck, et al.Antimicrobial Agents and Chemotherapy|September 6, 2022
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Collected through CDC's Emerging Infections Program, United States, 2016-2018Richard A Stanton, Davina Campbell, Gillian A McAllister, et al.Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.Pageof 130